ARTICLE | Company News
PGNX, UR Labs in licensing deal
October 1, 2001 7:00 AM UTC
Progenics (PGNX) received an exclusive worldwide license from UR Labs (Chicago, Ill.) to methylnaltrexone (MNTX), an opioid receptor antagonist in Phase II testing to treat opioid-induced constipation...